A retrospective multicenter cohort study assessing the tumor necrosis factor (TNF) inhibitor therapy on ocular relapses in patients diagnosed with Susac syndrome
Latest Information Update: 07 Apr 2021
At a glance
- Drugs Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Corticosteroids
- Indications Autoimmune disorders; Cerebrovascular disorders; Ear nose and throat disorders
- Focus Therapeutic Use
- 07 Apr 2021 New trial record